LCI 1318 (Terbutaline 2.5 mg)
Pill imprint LCI 1318 has been identified as Terbutaline sulfate 2.5 mg.
Terbutaline is used in the treatment of premature labor; asthma, acute; asthma, maintenance and belongs to the drug classes adrenergic bronchodilators, tocolytic agents. There is no proven risk in humans during pregnancy. Terbutaline 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- LCI 1318
- Strength:
- 2.5 mg
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Adrenergic bronchodilators
Tocolytic agents - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Lannett Company, Inc.
- National Drug Code (NDC):
- 00527-1318
- Inactive Ingredients:
- microcrystalline cellulose
lactose anhydrous
magnesium stearate
povidone
pregelatinized corn starch
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0256 | Amerisource Health Services |
| 10135-0579 | Marlex Pharmaceuticals Inc |
Note: Inactive ingredients may vary.
More about terbutaline
Consumer resources
- Terbutaline
- Terbutaline tablets
- Terbutaline (Advanced Reading)
- Terbutaline Subcutaneous (Advanced Reading)
- Other brands: Brethine
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
